JPS51130522A - Cephazolin suspension for nonnaural administration - Google Patents

Cephazolin suspension for nonnaural administration

Info

Publication number
JPS51130522A
JPS51130522A JP51039139A JP3913976A JPS51130522A JP S51130522 A JPS51130522 A JP S51130522A JP 51039139 A JP51039139 A JP 51039139A JP 3913976 A JP3913976 A JP 3913976A JP S51130522 A JPS51130522 A JP S51130522A
Authority
JP
Japan
Prior art keywords
nonnaural
cephazolin
administration
suspension
nonnaural administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51039139A
Other languages
English (en)
Japanese (ja)
Inventor
Borunsutein Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS51130522A publication Critical patent/JPS51130522A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP51039139A 1975-04-28 1976-04-06 Cephazolin suspension for nonnaural administration Pending JPS51130522A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/573,283 US4029782A (en) 1975-04-28 1975-04-28 Cefazolin suspension for parenteral administration

Publications (1)

Publication Number Publication Date
JPS51130522A true JPS51130522A (en) 1976-11-12

Family

ID=24291351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51039139A Pending JPS51130522A (en) 1975-04-28 1976-04-06 Cephazolin suspension for nonnaural administration

Country Status (8)

Country Link
US (1) US4029782A (https=)
JP (1) JPS51130522A (https=)
AU (1) AU505940B2 (https=)
BE (1) BE841157A (https=)
DE (1) DE2618422A1 (https=)
FR (1) FR2309211A1 (https=)
GB (1) GB1546479A (https=)
ZA (1) ZA761476B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
GB8322364D0 (en) * 1983-08-19 1983-09-21 May & Baker Ltd Compositions of matter
US6660049B1 (en) 1996-07-31 2003-12-09 Natural Soda Aala, Inc. Process for control of crystallization of inorganics from aqueous solutions
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
RU2310450C2 (ru) * 2002-10-25 2007-11-20 Пфайзер Продактс Инк. Новые депо-препараты для инъекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297692A (en) * 1961-04-03 1967-01-10 Lilly Co Eli 7-alkylmercaptoacetamidocephalosporanic acid
GB1051746A (https=) * 1961-12-22
US3293133A (en) * 1963-04-24 1966-12-20 Squibb & Sons Inc Method of imparting color to pharmaceutical solutions
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines
US3678163A (en) * 1969-06-02 1972-07-18 Merck & Co Inc Stabilized aqueous suspension of calcium (-) (cis-1,2-epoxypropyl)-phosphonate
US3897423A (en) * 1973-03-05 1975-07-29 Squibb & Sons Inc Amino substituted acylthio cephalosporins

Also Published As

Publication number Publication date
ZA761476B (en) 1977-10-26
BE841157A (fr) 1976-10-27
AU1186876A (en) 1977-09-15
DE2618422A1 (de) 1976-11-11
FR2309211B1 (https=) 1979-03-23
GB1546479A (en) 1979-05-23
US4029782A (en) 1977-06-14
FR2309211A1 (fr) 1976-11-26
AU505940B2 (en) 1979-12-06

Similar Documents

Publication Publication Date Title
ZA766730B (en) Capsules
HK23979A (en) Piperidyl-triazine derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
GB1520812A (en) Benzhydrylsulphinyl derivatives
GB1546958A (en) Bottom bracket assemblies for bicvcles
GB1533377A (en) Polyphenyl derivatives
GB1548621A (en) Nhydrovinca derivatives
AU2015876A (en) Parenteral administration set
ZA765331B (en) Novel pharmaceutically active compounds
AU1597876A (en) Ortho-aminobutyrophenone derivatives
JPS51130522A (en) Cephazolin suspension for nonnaural administration
ZA761324B (en) Pharmaceutically active compounds
GB1540574A (en) Medicament for remedying schizophrenia
GB1540845A (en) 6-oxo-pyrimidine derivatives
AU1074176A (en) Oxadiazolinone derivatives
JPS51139614A (en) Medical suspension for gelatin capsullae
JPS521038A (en) Medicine for convulsion tranquillity
CY1151A (en) Cis-bicyclooctyl-alkyl-amine derivatives
JPS5279597A (en) Structure for dialyzer
JPS51148034A (en) Medicine for round alopecia
GB1554720A (en) Pyridthione derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
GB1487036A (en) Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives
AU1661376A (en) Morphanthridine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives